Artificial intelligence (ai) in clinical trials market insights, competitive landscape, and forecasts report 2025-2032 featuring key players such as tempus, netramark, concertai, aicure, and oracle

The ai in clinical trials market is driven by the surge in chronic diseases and increased pharma collaborations. valued at $1.35 billion in 2024, it aims to reach $3.33 billion by 2032. north america leads due to investment in r&d and numerous trials. the ai in clinical trials market is driven by the surge in chronic diseases and increased pharma collaborations. valued at $1.35 billion in 2024, it aims to reach $3.33 billion by 2032. north america leads due to investment in r&d and numerous trials.
ORCL Ratings Summary
ORCL Quant Ranking